SS Innovations International (NASDAQ:SSII) Shares Down 7.4% – Should You Sell?

SS Innovations International, Inc. (NASDAQ:SSII)’s share price traded down 7.4% on Thursday . The company traded as low as $3.93 and last traded at $3.99. 107,155 shares were traded during trading, an increase of 40% from the average session volume of 76,300 shares. The stock had previously closed at $4.31.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SS Innovations International in a research report on Tuesday, April 21st. Loop Capital set a $7.00 target price on SS Innovations International in a report on Wednesday. Finally, Wall Street Zen raised SS Innovations International from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell” and an average price target of $7.00.

SS Innovations International Price Performance

The stock’s 50 day moving average is $4.36 and its 200-day moving average is $4.93. The company has a market capitalization of $783.51 million, a P/E ratio of -78.20 and a beta of -1.88.

SS Innovations International (NASDAQ:SSII) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.02) earnings per share for the quarter. SS Innovations International had a negative net margin of 20.69% and a negative return on equity of 23.00%. The firm had revenue of $11.10 million for the quarter.

Insider Buying and Selling

In other SS Innovations International news, CEO Srivastava Sudhir bought 498,753 shares of the company’s stock in a transaction dated Friday, March 6th. The shares were purchased at an average price of $4.01 per share, for a total transaction of $1,999,999.53. Following the acquisition, the chief executive officer owned 109,851,767 shares in the company, valued at approximately $440,505,585.67. This represents a 0.46% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Frederic H. Moll bought 501,253 shares of SS Innovations International stock in a transaction dated Friday, March 6th. The stock was acquired at an average cost of $3.99 per share, for a total transaction of $1,999,999.47. Following the completion of the transaction, the director directly owned 10,775,485 shares in the company, valued at approximately $42,994,185.15. This trade represents a 4.88% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought a total of 1,300,006 shares of company stock valued at $5,196,999 over the last ninety days.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. PNC Financial Services Group Inc. bought a new stake in SS Innovations International during the third quarter worth about $56,000. Envestnet Asset Management Inc. purchased a new position in shares of SS Innovations International during the third quarter valued at approximately $71,000. Jane Street Group LLC bought a new stake in shares of SS Innovations International in the 4th quarter worth approximately $63,000. IFC & Insurance Marketing Inc. purchased a new stake in shares of SS Innovations International in the 4th quarter worth approximately $64,000. Finally, Goldman Sachs Group Inc. purchased a new stake in shares of SS Innovations International in the 4th quarter worth approximately $68,000.

SS Innovations International Company Profile

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.